A retrospective study of arterial stiffness and subsequent clinical outcomes in cancer patients undergoing percutaneous coronary intervention.


Journal

Journal of hypertension
ISSN: 1473-5598
Titre abrégé: J Hypertens
Pays: Netherlands
ID NLM: 8306882

Informations de publication

Date de publication:
04 2019
Historique:
entrez: 1 3 2019
pubmed: 1 3 2019
medline: 10 6 2020
Statut: ppublish

Résumé

Increasing attention is being paid to the relationship between cancer and cardiovascular diseases. In this study, we examined arterial stenosis and stiffness in patients with malignant diseases requiring percutaneous coronary intervention. This was a retrospective, single-center, observational study. Participants (n = 1003) were divided into a malignant group, with current or past malignant disease, and a nonmalignant group. The ankle-brachial index (ABI) and brachial-ankle pulse wave velocity (baPWV) were evaluated. The endpoint was a composite of cardiovascular death, nonfatal myocardial infarction, stroke, and revascularization within 1 year. We observed significantly impaired ABI and baPWV in the malignant group. A total of 148 patients had a cardiovascular event. Kaplan-Meier analysis showed a significantly higher probability of cardiovascular events in the malignant group (P = 0.012). The combination of malignancy with ABI/baPWV identified subgroups with significantly different probabilities of cardiovascular events. Multivariate Cox hazard analysis identified malignancy as an independent predictor of cardiovascular events (hazard ratio, 1.54; 95% confidence interval, 1.06-2.26; P = 0.025) with an increased hazard ratio by adding the status of low ABI/high baPWV to malignancy (hazard ratio, 2.36; 95% confidence interval, 1.35-4.12; P = 0.003). We found significantly higher follow-up baPWV values in the malignancy group (P = 0.016). Atherosclerosis is advanced and accelerated in patients with malignancy, and these patients had significantly higher rates of adverse cardiovascular events, and their risk might be stratified by ABI and baPWV. University Hospital Medical Information Network-CTR (http://www.umin.ac.jp/ctr/). Kumamoto University Malignancy and Atherosclerosis study (UMIN000028652). Opt-out materials are available at the following website: http://www.kumadai-junnai.com/home/wp-content/uploads/akusei.pdf.

Identifiants

pubmed: 30817457
doi: 10.1097/HJH.0000000000001949
pii: 00004872-201904000-00015
doi:

Banques de données

UMIN-CTR
['UMIN000028652']

Types de publication

Journal Article Observational Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

754-764

Auteurs

Noriaki Tabata (N)

Department of Cardiovascular Medicine.
Center for Metabolic Regulation of Healthy Aging.

Daisuke Sueta (D)

Department of Cardiovascular Medicine.
Center for Metabolic Regulation of Healthy Aging.

Eiichiro Yamamoto (E)

Department of Cardiovascular Medicine.
Center for Metabolic Regulation of Healthy Aging.

Seiji Takashio (S)

Department of Cardiovascular Medicine.
Center for Metabolic Regulation of Healthy Aging.

Yuichiro Arima (Y)

Department of Cardiovascular Medicine.
Center for Metabolic Regulation of Healthy Aging.

Satoshi Araki (S)

Department of Cardiovascular Medicine.
Center for Metabolic Regulation of Healthy Aging.

Kenshi Yamanaga (K)

Department of Cardiovascular Medicine.
Center for Metabolic Regulation of Healthy Aging.

Masanobu Ishii (M)

Department of Cardiovascular Medicine.
Center for Metabolic Regulation of Healthy Aging.

Kenji Sakamoto (K)

Department of Cardiovascular Medicine.
Center for Metabolic Regulation of Healthy Aging.

Hisanori Kanazawa (H)

Department of Cardiovascular Medicine.
Center for Metabolic Regulation of Healthy Aging.

Koichiro Fujisue (K)

Department of Cardiovascular Medicine.
Center for Metabolic Regulation of Healthy Aging.

Shinsuke Hanatani (S)

Department of Cardiovascular Medicine.
Center for Metabolic Regulation of Healthy Aging.

Hirofumi Soejima (H)

Department of Cardiovascular Medicine.
Center for Metabolic Regulation of Healthy Aging.

Seiji Hokimoto (S)

Department of Cardiovascular Medicine.
Center for Metabolic Regulation of Healthy Aging.

Yasuhiro Izumiya (Y)

Department of Cardiovascular Medicine.
Center for Metabolic Regulation of Healthy Aging.

Sunao Kojima (S)

Department of Cardiovascular Medicine.
Center for Metabolic Regulation of Healthy Aging.

Hiroshige Yamabe (H)

Department of Cardiovascular Medicine.
Center for Metabolic Regulation of Healthy Aging.

Koichi Kaikita (K)

Department of Cardiovascular Medicine.
Center for Metabolic Regulation of Healthy Aging.

Kunihiko Matsui (K)

Department of Community, Family, and General Medicine, Graduate School of Medical Sciences, Kumamoto University, Kumamoto, Japan.

Kenichi Tsujita (K)

Department of Cardiovascular Medicine.
Center for Metabolic Regulation of Healthy Aging.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH